QuickMD logo

QuickMD Review

7.4
★★★★☆3.7/5

GLP-1 weight-loss telehealth · Independently scored 7.4/10

Best for: same-day $99 visits for a brand-name GLP-1 prescription

QuickMD's strongest dimension is the sign-up and app experience.

What the plan covers

Medication

Not disclosed

Provider visits

Not disclosed

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

QuickMD is a high-volume telemedicine platform (over 2 million visits) offering same-day online weight-management visits for $99 per consultation, with no membership. Its clinicians can prescribe brand-name GLP-1s including Wegovy (injection or tablet), Zepbound, Ozempic, Mounjaro and Rybelsus; medication is filled at your pharmacy and priced separately, and QuickMD publishes no medication price. Its compounded semaglutide and tirzepatide pages now say those drugs are no longer available. Visits run by phone or video, 365 days a year, in 45-plus states (not Louisiana for weight loss).

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Brand GLP-1 RxSame-day visitsNo membership45+ states100% online365 days/yearCash-pay pricing2M+ visits

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to QuickMD

8.2/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★☆4.1/5

Editorial score · methodology

$112/mosemaglutide
$169/motirzepatide
CompoundedSemaglutideTirzepatideNAD+
Get StartedRead full Enhance MD review →
7.1/ 10
Verified partner

MEDVi

Best for: switching between compounded and brand-name GLP-1 through one provider

★★★★☆3.6/5

Editorial score · methodology

$249/mosemaglutide
CompoundedSemaglutideTirzepatideFDA Warning
Get StartedRead full MEDVi review →
6.9/ 10
Verified partner

DudeMeds

Best for: men seeking no-fee compounded or brand-name GLP-1 injections

★★★★☆3.5/5

Editorial score · methodology

$175/mosemaglutide
$233/motirzepatide
CompoundedSemaglutideTirzepatideNAD+
Get StartedRead full DudeMeds review →
QuickMD logo
3.7 / 5
Our editorial rating
Visit QuickMD →

QuickMD at a glance

Type
GLP-1 telehealth provider
FDA status
No FDA warning letter on record

How we scored QuickMD

Each dimension is scored algorithmically from QuickMD’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

7.3/10

QuickMD does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.

Effectiveness25%

6.7/10

QuickMD's offering is not built around the GLP-1 molecules with the strongest weight-loss trial evidence — weigh the clinical support carefully.

User Experience15%

8.4/10

Online intake and platform experience; 8 platform features disclosed.

Trust & Safety15%

8.2/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

7.3/10

QuickMD's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

7.1/10

QuickMD provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
635providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this QuickMD review

Last checked October 2026
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with QuickMD

We walked QuickMD’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Answer questions about what you're looking for; the site shows matching doctors.
  2. 2Choose an available provider in your state and book an appointment time.
  3. 3Before the appointment: verify ID, complete the intake form, and use the app or browser.
  4. 4Connect with the doctor by private phone or online video call.
Price shown before you startLive video visit required
  • $99/consultation is shown, but no monthly medication price is published ('price does not include cost of medication').
  • A real-time doctor visit (phone or video) is required.
  • No membership required; cash-pay, no insurance.
  • Offers tirzepatide (Mounjaro/Zepbound) and semaglutide (Wegovy/Ozempic/Rybelsus).

What we like

  • Flat $99 weight-loss consultation with no membership and no surprise fees
  • Same-day, 365-day-a-year online visits
  • Large established platform with over 2 million completed visits
  • Can prescribe Wegovy (injection or tablet), Zepbound, Ozempic, Mounjaro, Rybelsus
  • Visit summaries for possible reimbursement; HSA/FSA cards can typically be used
  • Established patients may qualify for 90-day prescriptions

Watch-outs

  • Does not accept insurance
  • Available in 45+ states, not all 50; weight-loss visits not offered in Louisiana
  • Medication is priced by your pharmacy and not bundled; no medication price published
  • Its compounded semaglutide and tirzepatide pages say those drugs are no longer available
  • No refund once a visit is completed, and a $35 fee for a missed visit
  • No named board-certified physicians listed publicly

QuickMD: a high-volume telehealth platform built around the visit, not a medication bundle

QuickMD is not a boutique weight-loss brand. It is a large, general telemedicine platform that has logged more than 2 million completed visits across many kinds of care, and weight management is one lane inside that bigger operation. That scale is the first thing worth understanding about it. You are buying access to a same-day clinician on a system that runs every day of the year, in 45-plus states, entirely by phone or video. If your priority is getting in front of a licensed prescriber quickly and getting a brand-name semaglutide or tirzepatide prescription written, QuickMD is built for exactly that. If your priority is a tidy all-in monthly price with the medication included in the box, this is not that kind of service, and you should know that going in.

How the money actually works here

QuickMD's current model is a consult-fee model, not a subscription. You pay $99 for a weight-loss consultation with a licensed doctor who assesses you and, if it's appropriate, writes a GLP-1 prescription. Some patients may also be asked for lab tests. The medication itself is billed separately, and its cost depends entirely on which pharmacy fills the script and what, if any, drug coverage you have. There is no membership, no recurring platform charge, and the company is explicit that there are no surprise fees layered on top of the visit.

Two terms are worth knowing before you book. A missed visit costs $35, and once a visit is completed it isn't refunded, even if you don't end up with a prescription. QuickMD publishes no medication price at all, so there's no monthly figure to compare against the category median of about $179 a month. Your real monthly cost is whatever your pharmacy charges for the drug you're prescribed. Established patients may qualify for 90-day prescriptions, which can cut the number of visits you pay for.

How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 508 GLP-1 providers we track.

The medications: brand GLP-1s, dispensed through outside pharmacies

This is one of QuickMD's genuine strengths. Its clinicians can prescribe the full slate of brand-name GLP-1s, including Wegovy as an injection or a tablet, Zepbound, Ozempic and Mounjaro, as well as oral Rybelsus and liraglutide (Victoza). QuickMD's compounded semaglutide and tirzepatide pages now say those drugs are no longer available "due to FDA regulations," so plan on a brand-name prescription. Many cash-pay weight-loss services funnel everyone toward a single compounded formulation because that's what they bundle and profit from. QuickMD instead writes the prescription and lets you fill it where it makes sense for you. That flexibility matters if your insurance happens to cover a brand drug, or if you want to shop the manufacturers' own cash programs.

The trade-off is the flip side of that same coin: because the drug is filled by an outside pharmacy, your real monthly cost is unpredictable until you actually price the prescription. A brand GLP-1 without coverage can run well over a thousand dollars a month at retail; the same drug with good coverage can be a modest copay. QuickMD gives you the script and a visit summary you can submit for possible reimbursement, and HSA/FSA cards can typically be used, but it does not bill insurance itself, and it cannot promise you a price on a medication it isn't dispensing.

What genuinely sets QuickMD apart

The real differentiator is speed and reach backed by a track record. Same-day visits, 365 days a year, on a platform that has handled over 2 million visits and reports very high patient satisfaction, is a meaningfully different proposition from a newer startup. You are unlikely to wait days for an appointment, and you're not depending on a single small clinic's hours. For people who want to start a GLP-1 conversation today, that responsiveness is the headline feature — more than any single price.

  • Same-day, phone-or-video visits available every day of the year
  • Prescribes brand GLP-1s (Wegovy as an injection or tablet, Zepbound, Ozempic, Mounjaro) and oral Rybelsus
  • A $99 consult fee with no membership and no recurring platform charge
  • Provides itemized visit summaries you can submit for possible insurance reimbursement
  • Established platform with 2 million-plus completed visits across its telehealth services

Who should choose it — and who should skip it

Choose QuickMD if you want fast, low-commitment access to a prescriber, you're comfortable filling your medication at an outside pharmacy, and you want a brand-name GLP-1 rather than a house compounded formula. It's a sensible fit for someone who already has some drug coverage, or who wants a clinician's prescription without locking into a monthly program.

Skip it if you want one predictable number that covers everything. Because the medication is priced by your pharmacy, your total monthly spend can swing widely, and budgeting is harder than it is with a fully bundled competitor. Skip it too if you live in one of the states QuickMD doesn't yet serve. It's in 45-plus states, not all 50, and weight-loss visits aren't offered in Louisiana. The same goes if having insurance billed directly is important to you, since this is strictly cash-pay.

Trust, safety and medical oversight

On the reassuring side, there are no FDA warning letters on file for QuickMD, and visits are conducted by licensed clinicians on a long-running, high-volume platform — the kind of operating history that's hard to fake. On the cautious side, QuickMD does not publish the names or credentials of the board-certified physicians leading its weight program. It doesn't enumerate its exact state list publicly either. None of that is a red flag, but it does mean you're trusting the platform's process more than a named medical director. As always, weigh this against your own situation and read our scoring methodology for how we grade these factors.

Bottom line

QuickMD is a fast, flexible, cash-pay front door to GLP-1 treatment, strongest for people who want a quick prescription and the freedom to fill a brand-name drug at their own pharmacy. Its weakness is cost predictability: the medication is priced outside the visit, so your true monthly outlay depends on your pharmacy and coverage, not on QuickMD. Go in expecting to pay $99 for the visit and then to shop your prescription, and it's a solid, no-strings option. Want everything wrapped into one fixed monthly price? A fully bundled competitor will suit you better.

The Bottom Line

QuickMD's strongest dimension is the sign-up and app experience.

Score: 7.4/10Best for: same-day $99 visits for a brand-name GLP-1 prescription

Ready to start with QuickMD?

See current pricing and start your free consultation.

QuickMD might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
  • If you want built-in coaching and behavior-change support, consider MEDVi.

Frequently Asked Questions

QuickMD is a high-volume general telemedicine platform (more than 2 million completed visits) that offers many services, including same-day online weight-management care, and it is also known for urgent care and addiction (MAT) treatment. Visits are conducted entirely online by phone or video with licensed clinicians, and a clinician determines whether GLP-1 treatment is appropriate for you.
A weight-loss consultation costs $99 per visit, with no membership and no insurance billing. Medication is billed separately by your pharmacy, and its cost depends on the drug prescribed and the pharmacy you choose; QuickMD doesn't publish a medication price. A missed visit carries a $35 fee, and completed visits aren't refunded.
QuickMD's clinicians can prescribe brand-name, FDA-approved GLP-1s including Wegovy (injection or tablet), Zepbound, Ozempic, Mounjaro and oral Rybelsus, plus liraglutide (Victoza). Its compounded semaglutide and tirzepatide pages now say those drugs are no longer available due to FDA regulations, though its FAQ says compounding may be an option for patient-specific needs. The clinician decides what is appropriate for you, and medication cost depends on your pharmacy.
QuickMD says it serves 45-plus states, with visits offered 365 days a year; weight-loss visits are not available in Louisiana. Availability is confirmed when you book.
No. QuickMD uses cash-pay pricing and does not bill insurance, though it provides visit summaries you may submit for possible reimbursement, and HSA/FSA cards can typically be used. Medication is billed separately through your pharmacy and is not bundled into the visit fee.
You book a same-day online visit by phone or video with a licensed clinician, who assesses your needs, may order lab tests, and prescribes a GLP-1 if appropriate. Established patients may qualify for 90-day prescriptions. QuickMD reports high visit volume and satisfaction, though individual physicians are not named publicly on the site.
QuickMD doesn't use public promo or coupon codes. Third-party sites advertising "QuickMD discount codes" are typically fake; any current offer applies automatically through the link on this page.
Yes — QuickMD is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.4/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Does not accept insurance; Available in 45+ states, not all 50; weight-loss visits not offered in Louisiana; Medication is priced by your pharmacy and not bundled; no medication price published; Its compounded semaglutide and tirzepatide pages say those drugs are no longer available. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this QuickMD review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.

See QuickMD's current pricing

Start your free consultation to check eligibility and today's price.